Globally, vaccine researchers are working on nonantibiotic methods to prevent recurrent urinary tract infections (rUTIs) as antibiotic resistance becomes a growing threat to this painful disease.
In the United States, about 40% of women develop a UTI at some point in their lifetime, as well as many men.
According to an article by Carissa Wong published in the journal Nature on May 2, 2024, the latest prevention approaches include an oral spray vaccine.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
